Full FDA approval of covid-19 vaccines might lead more people to get them. What’s the holdup? The Philadelphia Inquirer AP
TribLIVE's Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox. PHILADELPHIA — More than eight months ago, large studies found that both the Pfizer-BioNTech and Moderna covid-19 vaccines reduced the risk of illness by more than 90%. Yet the U.S. Food and Drug Administration has not yet granted them full approval, to the dismay of public-health officials eager to boost vaccination rates as the delta variant sends infections skyward. So what’s the holdup?